These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28941313)

  • 1. Different intervention strategies for preventing type 2 diabetes mellitus in China: A systematic review and network meta-analysis of randomized controlled trials.
    Pang B; Zhao LH; Li XL; Song J; Li QW; Liao X; Feng S; Zhao XY; Zheng YJ; Gou XW; Ni Q; Tong XL
    Diabetes Obes Metab; 2018 Mar; 20(3):718-722. PubMed ID: 28941313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
    Yang J; Huang C; Wu S; Xu Y; Cai T; Chai S; Yang Z; Sun F; Zhan S
    PLoS One; 2017; 12(12):e0187537. PubMed ID: 29206832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
    Lan J; Zhao Y; Dong F; Yan Z; Zheng W; Fan J; Sun G
    J Ethnopharmacol; 2015 Feb; 161():69-81. PubMed ID: 25498346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis.
    Yamaoka K; Nemoto A; Tango T
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31248094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Single- or Double-Drug Antidiabetic Regimens in the Treatment of Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Yang XL; Duo-Ji MM; Long ZW
    J Cell Biochem; 2017 Dec; 118(12):4536-4547. PubMed ID: 28471499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
    Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
    Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis.
    Phung OJ; Baker WL; Tongbram V; Bhardwaj A; Coleman CI
    Ann Pharmacother; 2012 Apr; 46(4):469-76. PubMed ID: 22474136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network meta-analysis for efficacy and safety of seven regimens in the treatment of type II diabetes.
    Wang LG; Wang H; Liu Q; Hua WC; Li CM
    Biomed Pharmacother; 2017 Aug; 92():707-719. PubMed ID: 28586742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
    Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
    Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategies for the prevention of elderly-onset type 2 diabetes mellitus].
    Toyonaga T; Araki E
    Nihon Rinsho; 2006 Jan; 64(1):140-3. PubMed ID: 16408462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type 2 diabetes with the traditional Chinese patent medicine: A systematic review and meta-analysis.
    Pang B; Lian FM; Zhao XY; Zhao XM; Jin D; Lin YQ; Zheng YJ; Ni Q; Tong XL
    Diabetes Res Clin Pract; 2017 Sep; 131():242-259. PubMed ID: 28780370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs.
    Fei Y; Tsoi MF; Kumana CR; Cheung TT; Cheung BMY
    Int J Cardiol; 2018 Mar; 254():291-296. PubMed ID: 29277321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design.
    Grenet G; Lajoinie A; Ribault S; Nguyen GB; Linet T; Metge A; Cornu C; Cucherat M; Moulin P; Gueyffier F
    Fundam Clin Pharmacol; 2017 Jun; 31(3):258-264. PubMed ID: 28036112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Wu S; Chai S; Yang J; Cai T; Xu Y; Yang Z; Zhang Y; Ji L; Sun F; Zhan S
    Clin Ther; 2017 Sep; 39(9):1780-1789.e33. PubMed ID: 28827024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.
    Dai X; Wang H; Jing Z; Fu P
    Curr Med Res Opin; 2014 Sep; 30(9):1777-86. PubMed ID: 24805140
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.